Tarsus Pharmaceuticals
Price & Volume
Stats
See more52W Range | $38.51-$85.25 |
Market Cap | $3.3B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $366.1M |
Revenue Growth (YoY) | 146.7% |
Gross Profit (12 Mos) | $278.2M |
Diluted EPS | -$1.99 |
News
See moreYahoo Finance • 2 months ago
Tarsus to Participate in Upcoming Investor Conference
Yahoo Finance • 2 months ago
Tarsus outlines $140M–$145M Q4 sales target while expanding XDEMVY adoption and pipeline progress
Yahoo Finance • 2 months ago
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
Yahoo Finance • 2 months ago
Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
About
CEO | Dr. Bobak R. Azamian M.D. |
CFO | Mr. Jeffrey S. Farrow CPA |
Address | 15440 Laguna Canyon Road, Irvine, CA, United States, 92618 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 323 |
